Notice Number: NOT-DA-17-007
Release Date: December 21, 2016
National Institute on Drug Abuse (NIDA)
The purpose of this Guide Notice is to announce new NIDA policy on salary allowance for the NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12) (PAR-15-119).
In June 2014, a Working Group of the Advisory Committee to the NIH Director (ACD) issued a report on the Physician Scientist Workforce (http://acd.od.nih.gov/psw.htm). The Working Group identified several challenges confronting physician-scientists, including individuals with MD, DO, DDS/DMD, DVM/VMD, or nurses with research doctoral degrees who devote the majority of their time to biomedical research. The Working Group made several recommendations to the ACD about the funding and training of physician scientists in order to attract and retain well-qualified individuals in research careers, including the modification of some current NIH programs.
On December 17, 2015, the NIH issued a Guide Notice (NOT-OD-16-032), as well as a subsequent Notice (NOT-OD-16-054) on January 20, 2016, to increase NIH contribution toward K08 and K23 awardees’ salary support to a base level of $100,000. In the spirit of this policy change, NIDA announces this increase for the NIDA K12 program to ensure that both institutional and individual career development opportunities remain equally viable options for clinician scientists focusing on substance abuse and/or addiction research.
NIDA will increase its contribution toward K12 scholar salary support to $100,000 for the NIDA Mentored Clinical Scientists Development Program Award in Drug Abuse and Addiction (K12). This policy applies to new (Type 1) and renewal (type 2) applications submitted in response to PAR-15-119 as well as all continuation (Type 5) applications submitted for FY 2017 funding.
Please direct inquiries to:
National Institute on Drug Abuse